MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Pulmatrix Inc

Fermé

6.06 -4.72

Résumé

Variation du prix de l'action

24h

Actuel

Min

6.06

Max

6.45

Chiffres clés

By Trading Economics

Revenu

178K

-1.8M

Marge bénéficiaire

-60,266.667

Employés

2

EBITDA

144K

-1.8M

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.1M

24M

Ouverture précédente

10.78

Clôture précédente

6.06

Pulmatrix Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 juil. 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 juil. 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 juil. 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 juil. 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 juil. 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 juil. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 juil. 2025, 20:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

15 juil. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 juil. 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15 juil. 2025, 20:14 UTC

Acquisitions, Fusions, Rachats

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 juil. 2025, 20:07 UTC

Résultats

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 juil. 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 juil. 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15 juil. 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 juil. 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 juil. 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 juil. 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 juil. 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15 juil. 2025, 18:32 UTC

Acquisitions, Fusions, Rachats

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 juil. 2025, 18:31 UTC

Acquisitions, Fusions, Rachats

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 juil. 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 juil. 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 juil. 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 juil. 2025, 17:25 UTC

Acquisitions, Fusions, Rachats

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 juil. 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15 juil. 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 juil. 2025, 16:20 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

15 juil. 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 juil. 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 juil. 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Comparaison

Variation de prix

Pulmatrix Inc prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.